OMERS ADMINISTRATION Corp Acquires 97,968 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• OMERS ADMINISTRATION Corp increased its stake in UnitedHealth Group by 57.3%, now holding 269,089 shares worth approximately $140.9 million, making it the company's 23rd largest position.
• UnitedHealth Group's recent quarterly earnings reported an EPS of $4.08, falling short of expectations by $0.37, while revenue was $111.62 billion, slightly below analyst estimates.
• The company announced a quarterly dividend of $2.21 per share, which equates to an annualized yield of 2.9%, with the ex-dividend date set for September 15th.

OMERS ADMINISTRATION Corp grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 57.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 269,089 shares of the healthcare conglomerate's stock after acquiring an additional 97,968 shares during the quarter. UnitedHealth Group accounts for about 1.2% of OMERS ADMINISTRATION Corp's investment portfolio, making the stock its 23rd largest holding. OMERS ADMINISTRATION Corp's holdings in UnitedHealth Group were worth $140,935,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of UNH. GAMMA Investing LLC increased its holdings in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Nuveen LLC bought a new position in shares of UnitedHealth Group during the first quarter worth about $3,846,764,000. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research reports. Morgan Stanley decreased their price objective on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating for the company in a report on Wednesday, August 20th. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. KeyCorp reduced their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Truist Financial reduced their price target on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. Finally, Royal Bank Of Canada reduced their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $353.00.

UnitedHealth Group Stock Performance

Shares of UNH traded up $7.48 during mid-day trading on Friday, reaching $309.77. The company's stock had a trading volume of 12,018,847 shares, compared to its average volume of 20,287,358. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $280.55 billion, a P/E ratio of 13.42, a PEG ratio of 1.95 and a beta of 0.43. The business has a 50-day simple moving average of $288.16 and a two-hundred day simple moving average of $381.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business earned $6.80 earnings per share. The business's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.